# Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

> **NCT01325584** · PHASE2 · TERMINATED · sponsor: **Midwestern Regional Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Cancer
- Hepatic Injury

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT01325584
- **Lead sponsor:** Midwestern Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-04
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Alternative product is now approved and available for use.
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325584, "Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01325584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*